Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Carriers of apolipoprotein E
4 allele seem particularly susceptible to their
effects
EditorWe agree with Rupert McShane and colleagues that there is evidence for
an association between treatment with neuroleptic drugs and a more rapid cognitive decline in
dementia, but we would also point out an additional association with the apolipoprotein
4
allele.1 We followed up 135 subjects from the Camberwell
dementia case register.2 The patients all fulfilled the criteria
of the National Institute of Neurological and Communicative Disorders and Stroke and the
Alzheimer's Disease and Related Disorders Association criteria for Alzheimer's
disease and had an initial score on the mini mental state examination of
5 points (to avoid
floor effects) over one year. Throughout this period 23 took neuroleptics and 112 had no
evidence of use of neuroleptics. Neither age; sex; initial score on the minimental state
examination; nor previous evidence of hallucinations, persecutory ideation, aggression, or sleep
disturbance
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?